Home › Funds › LVM CAPITAL MANAGEMENT LTD/MI › VRTX

LVM CAPITAL MANAGEMENT LTD/MI position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

LVM CAPITAL MANAGEMENT LTD/MI reported holding 23,610 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$12.3M, representing 1.05% of its reported portfolio and ranking #28 among its reported holdings. LVM CAPITAL MANAGEMENT LTD/MI has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)23.61K sh
Reported value held$12.34M
Portfolio Weight1.05%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LVM CAPITAL MANAGEMENT LTD/MI's VRTX position evolved

LVM CAPITAL MANAGEMENT LTD/MI first disclosed a stake in VRTX in Q3 2023 at 30,055 shares (US$10.5M). The position peaked in Q1 2025 at 29,913 shares, worth US$14.5M. Across 13 filings, LVM CAPITAL MANAGEMENT LTD/MI increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 23,610 shares valued at US$12.3M — a reduction of -1,376 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 30.05K $10.45M New
Q4 2023 30.10K $12.25M Hold
Q1 2024 30.41K $12.71M Add
Q2 2024 30.01K $14.07M Reduce
Q3 2024 30.01K $14.07M Hold
Q4 2024 30.38K $12.23M Add
Q1 2025 29.91K $14.50M Reduce
Q2 2025 30.07K $13.39M Add
Q3 2025 25.84K $10.12M Reduce
Q4 2025 25.77K $11.69M Hold
Q1 2026 25.83K $11.53M Hold
Q2 2026 24.99K $12.41M Reduce
Q3 2026 23.61K $12.34M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has LVM CAPITAL MANAGEMENT LTD/MI held VRTX?

LVM CAPITAL MANAGEMENT LTD/MI has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LVM CAPITAL MANAGEMENT LTD/MI's current position in VRTX?

As of Q3 2026, LVM CAPITAL MANAGEMENT LTD/MI holds 23.61K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $12.34M, representing 1.05% of its reported portfolio and ranking #28.

Has LVM CAPITAL MANAGEMENT LTD/MI been buying or selling VRTX?

In the latest 13F filing (Q3 2026), LVM CAPITAL MANAGEMENT LTD/MI reduced its position in VRTX. The position peaked in Q1 2025 at 29.91K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.